News
Watch
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Gideon Blumenthal, MD

Gideon Blumenthal, MD

Gideon Blumenthal, MD, is vice president of Clinical Development Oncology at Merck

Articles by Gideon Blumenthal, MD

D. Ross Camidge, MD, PhD; Gideon Blumenthal, MD, vice president, Clinical Development Oncology, Merck

How An Interest in Translational Research and Drug Development Helps Evolve Regulatory Practices: With D. Ross Camidge, MD, PhD; and Gideon Blumenthal, MD

ByRoss Camidge, MD, PhD,Gideon Blumenthal, MD

November 26th 2025

Drs Camidge and Blumenthal discussed Dr Blumenthal's experience serving on both sides of the oncology regulatory divide.

Latest Updated Articles

Trending on OncLive

FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria

Docetaxel Remains Unbeaten in Immunotherapy-Refractory NSCLC

Ris-Rez Meets Phase 3 Efficacy End Point for R/R Osteosarcoma

Cretostimogene Grenadenorepvec Elicits Durable Complete Responses and Bladder Preservation in BCG-Unresponsive NMIBC

Long-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings